Communiqués Astellas Pharma Inc.

Actions

4503

JP3942400007

Produits pharmaceutiques

Temps Différé Japan Exchange Autres places de cotation 02:01:34 24/07/2026			Varia. 5j.	Varia. 1 janv.
2 135,50 ^JPY	-1,18%		-0,56%	+2,05%

13/07	Pfizer et Astellas obtiennent le feu vert de la FDA pour leur traitement contre le cancer de la vessie	MT
10/07	Pfizer s'apprête à publier un deuxième trimestre mitigé, selon RBC	MT

Communiqués

09/04	Dyno Therapeutics Announces Capsid License Exercised by Astellas for Skeletal Muscle-Targeted Gene Delivery, Validating AI-Powered Technology for Biological Sequence Design	AQ
09/03	Astellas and Hovon Confirm Phase 3 Study Did not meet its Primary Endpoint of Overall Survival in Patients with Newly Diagnosed FLT3m+ AML	AQ
02/03	Astellas Pharma Inc. - PADCEV + Keytruda Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer	AQ
11/12	Astellas to Present New Clinical Data across Its Gastrointestinal Cancers Portfolio at 2026 ASCO GI Cancers Symposium	AQ
22/10/25	PADCEV (enfortumab vedotin-ejfv) Plus KEYTRUDA(R) (pembrolizumab) sBLA Granted FDA Priority Review for Treatment of Certain Patients with Muscle-Invasive Bladder Cancer	AQ
09/10/25	Astellas to Present New Data on IZERVAY in Geographic Atrophy at AAO 2025 Annual Meeting	AQ
26/09/25	China warns Japan businesses against spying after man convicted: sources	AQ
19/09/25	China tells Japan convicted man rewarded by intelligence agency	AQ
29/07/25	Ruling on Japanese businessman engaged in spying in China finalized	AQ
20/07/25	China pressed Japan businessman to admit to spying in plea deal	AQ
16/07/25	UPDATE1: Japan says detention of citizens in China hurting public sentiment	AQ
16/07/25	Japan says detention of citizens in China hurting public sentiment	AQ
16/07/25	UPDATE3: China court sentences Japanese man to 3.5-yrs in jail for spying	AQ
16/07/25	UPDATE2: Japanese man sentenced by China court to 3.5 yrs in prison for spying	AQ
16/07/25	Japanese man sentenced by China court to 3.5 yrs in prison for spying	AQ
16/07/25	China court to issue verdict in case of Japan man accused of spying	AQ
15/04/25	Chromatin Bioscience Signs Collaboration Agreement with Astellas	AQ
31/03/25	Japan envoy in China meets citizen detained for 2 yrs over espionage	AQ
13/02/25	U.S. FDA Approves Expanded Label for Astellas IZERVAY for Geographic Atrophy	AQ
06/02/25	Astellas Pharma Inc. - Recording of Extraordinary Losses in Non-consolidated Financial Results	AQ
09/01/25	Astellas Pharma, Inc. v. Sandoz Inc.	AQ
06/01/25	Astellas Pharma - China's National Medical Products Administration Approves VYLOY for First-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma	AQ
27/12/24	Axcelead DDP Enters into Drug Discovery Service Agreement with Astellas for Targeted Protein Degraders	AQ
21/10/24	Astellas VYLOY Approved by U.S. FDA for Treatment of Advanced Gastric and GEJ Cancer	AQ
04/10/24	Myrbetriq® Patent Invalidated On Grounds Not Asserted By Any Party Violating Party Presentation Principle	AQ